Vivos (RDGL) News Today $0.13 +0.00 (+3.29%) As of 05/28/2025 03:58 PM Eastern Add Compare Share Share Headlines Stock AnalysisChartHeadlinesSEC FilingsShort InterestBuy This Stock RDGL Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 Time Period Vivos (OTCMKTS:RDGL) versus Titan Medical (NASDAQ:TMDIF) Head to Head SurveyMay 27 at 1:49 AM | americanbankingnews.comVivos (OTCMKTS:RDGL) Trading 3.6% Higher - What's Next?Vivos (OTCMKTS:RDGL) Trading 3.6% Higher - Should You Buy?May 16, 2025 | marketbeat.comVivos Inc. Certifies University of Florida Veterinary Hospital for IsoPet® Precision Radionuclide Therapy™May 15, 2025 | globenewswire.comVivos Inc.May 8, 2025 | marketwatch.comVivos Inc. (OTCMKTS:RDGL) Sees Significant Increase in Short InterestVivos Inc. (OTCMKTS:RDGL - Get Free Report) was the target of a significant growth in short interest during the month of April. As of April 15th, there was short interest totalling 214,600 shares, a growth of 270.0% from the March 31st total of 58,000 shares. Based on an average daily trading volume, of 1,637,700 shares, the short-interest ratio is presently 0.1 days. Currently, 0.1% of the shares of the stock are short sold.April 29, 2025 | marketbeat.comVivos Inc. Achieves Record Growth in IsoPet® Animal Cancer Treatments in Q1 2025April 23, 2025 | globenewswire.comVivos Inc. Reports Continued Progress in India Human Clinical Trial for RadioGel® Precision Radionuclide Therapy™April 15, 2025 | globenewswire.comShort Interest in Vivos Inc. (OTCMKTS:RDGL) Decreases By 19.9%Vivos Inc. (OTCMKTS:RDGL - Get Free Report) was the recipient of a large decline in short interest in March. As of March 15th, there was short interest totalling 75,000 shares, a decline of 19.9% from the February 28th total of 93,600 shares. Based on an average daily trading volume, of 822,100 shares, the short-interest ratio is currently 0.1 days. Approximately 0.0% of the company's stock are sold short.April 1, 2025 | marketbeat.comVivos Inc. (OTCMKTS:RDGL) Sees Large Growth in Short InterestVivos Inc. (OTCMKTS:RDGL - Get Free Report) was the target of a large growth in short interest during the month of February. As of February 28th, there was short interest totalling 93,600 shares, a growth of 1,513.8% from the February 13th total of 5,800 shares. Approximately 0.0% of the company's shares are short sold. Based on an average daily volume of 3,207,700 shares, the short-interest ratio is presently 0.0 days.March 13, 2025 | marketbeat.comShort Interest in Vivos Inc. (OTCMKTS:RDGL) Drops By 67.8%Vivos Inc. (OTCMKTS:RDGL - Get Free Report) was the target of a large decrease in short interest in February. As of February 15th, there was short interest totalling 5,800 shares, a decrease of 67.8% from the January 31st total of 18,000 shares. Based on an average daily volume of 2,339,200 shares, the days-to-cover ratio is presently 0.0 days.March 1, 2025 | marketbeat.comShort Interest in Vivos Inc. (OTCMKTS:RDGL) Drops By 43.4%Vivos Inc. (OTCMKTS:RDGL - Get Free Report) saw a large drop in short interest during the month of January. As of January 31st, there was short interest totalling 18,000 shares, a drop of 43.4% from the January 15th total of 31,800 shares. Based on an average daily trading volume, of 1,799,300 shares, the days-to-cover ratio is presently 0.0 days.February 13, 2025 | marketbeat.comVivos Inc. Reports Encouraging Human Clinical Trial Results and Announces Expansion PlansFebruary 4, 2025 | finance.yahoo.comShort Interest in Vivos Inc. (OTCMKTS:RDGL) Expands By 25.7%Vivos Inc. (OTCMKTS:RDGL - Get Free Report) saw a significant increase in short interest during the month of January. As of January 15th, there was short interest totalling 31,800 shares, an increase of 25.7% from the December 31st total of 25,300 shares. Based on an average daily volume of 3,697,700 shares, the days-to-cover ratio is presently 0.0 days.February 2, 2025 | marketbeat.comVivos Inc. (OTCMKTS:RDGL) Sees Large Decline in Short InterestVivos Inc. (OTCMKTS:RDGL - Get Free Report) was the target of a significant drop in short interest in January. As of January 15th, there was short interest totalling 25,300 shares, a drop of 61.0% from the December 31st total of 64,900 shares. Based on an average trading volume of 3,461,200 shares, the days-to-cover ratio is presently 0.0 days.January 28, 2025 | marketbeat.comVivos Inc. (OTCMKTS:RDGL) Short Interest Down 61.0% in DecemberVivos Inc. (OTCMKTS:RDGL - Get Free Report) was the target of a significant decrease in short interest during the month of December. As of December 31st, there was short interest totalling 25,300 shares, a decrease of 61.0% from the December 15th total of 64,900 shares. Based on an average daily trading volume, of 3,461,200 shares, the short-interest ratio is presently 0.0 days.January 13, 2025 | marketbeat.comVivos Inc. (OTCMKTS:RDGL) Sees Significant Decrease in Short InterestVivos Inc. (OTCMKTS:RDGL - Get Free Report) saw a large decrease in short interest in the month of December. As of December 15th, there was short interest totalling 64,900 shares, a decrease of 27.5% from the November 30th total of 89,500 shares. Based on an average trading volume of 2,331,100 shares, the days-to-cover ratio is presently 0.0 days.December 28, 2024 | marketbeat.comVivos Inc.’s IsoPet® Division Achieves Exceptional Growth in 2024, Expanding Certified Veterinary Clinics NationwideDecember 27, 2024 | markets.businessinsider.comVivos Inc.'s IsoPet® Division Achieves Exceptional Growth in 2024, Expanding Certified Veterinary Clinics NationwideDecember 26, 2024 | globenewswire.comVivos Inc. Announces Launch of Groundbreaking RadioGel® Precision Radionuclide Therapy™ Human Clinical TrialDecember 23, 2024 | globenewswire.comVivos Therapeutics eyes positive cash flow as it continues cost-reduction success in Q3November 14, 2024 | proactiveinvestors.comVivos Inc. Certifies New Clinic for IsoPet® Precision Radionuclide TherapyTMOctober 18, 2024 | globenewswire.comVivos Inc. Extended its IsoPet® Precision Radionuclide TherapyTM to ExoticsSeptember 30, 2024 | finance.yahoo.comShort Interest in Vivos Inc. (OTCMKTS:RDGL) Drops By 70.1%Vivos Inc. (OTCMKTS:RDGL - Get Free Report) saw a large decrease in short interest during the month of August. As of August 31st, there was short interest totalling 35,200 shares, a decrease of 70.1% from the August 15th total of 117,700 shares. Based on an average trading volume of 1,728,700 shares, the days-to-cover ratio is presently 0.0 days.September 12, 2024 | marketbeat.comVivos Inc. (RDGL) Stock Price, News, Quote & History - Yahoo FinanceAugust 26, 2024 | finance.yahoo.comVivos Inc. Provides IDE Submission Status Update – Conversion to Pre-Sub Filing Accepted by the FDAJuly 29, 2024 | globenewswire.comVivos Inc. Submits the Application to the FDA for Authority to Initiate Human Clinical TrialsJune 28, 2024 | globenewswire.comVivos Inc. (RDGL) Latest Stock News & Headlines - Yahoo FinanceMay 15, 2024 | finance.yahoo.comBarchart’s Hot Penny Stocks Screener Identifies Opportunity in Vivos (RDGL)May 3, 2024 | msn.comVivos Inc. (RDGL)April 27, 2024 | finance.yahoo.comVivos Inc RDGLApril 15, 2024 | morningstar.comVivos Therapeutics, Inc: Vivos Therapeutics' Flagship CARE Oral Medical Devices Receive Full Approval for Medicare ReimbursementApril 11, 2024 | finanznachrichten.deVivos Stock (OTC:RDGL), Quotes and News SummaryMarch 23, 2024 | benzinga.comVivos IncFebruary 23, 2024 | thestreet.com3 Stocks to Turn $1,000 Into $1 Million: February 2024February 22, 2024 | investorplace.comSpeculation Tuesday: 2 Call Options and 1 Penny Stock to ConsiderJanuary 31, 2024 | theglobeandmail.comNew Hope In Cancer Battle: FDA Grants Breakthrough Device Status To Vivos Inc.'s RadioGelDecember 21, 2023 | msn.comRadiogel Precision Radionuclide Therapy Receives FDA Breakthrough Device DesignationDecember 20, 2023 | finance.yahoo.comRadiogel™ Precision Radionuclide Therapy™ Receives FDA Breakthrough Device DesignationDecember 20, 2023 | finance.yahoo.comVivos Inc. Announces Certification of Three New IsoPet® Precision Radionuclide Therapy Regional ClinicsAugust 7, 2023 | finance.yahoo.comVivos Inc. (RDGL) Stock Historical Prices & Data - Yahoo FinanceMay 15, 2023 | finance.yahoo.comVivos Inc Files a New Patent on Alternate Particles for Precision Radionuclide TherapyJanuary 11, 2023 | finance.yahoo.comRDGL.PK - Vivos Inc | Stock Price & Latest News | ReutersJanuary 5, 2023 | reuters.comVivos Inc Files a New Patent on Precision Radionuclide Therapy Support System EquipmentJanuary 3, 2023 | finance.yahoo.comVivos Inc Files a New Patent on the Hydrogel Component of IsoPet®/RadioGel(TM)September 15, 2022 | stockhouse.comVivos Inc Files a New Patent on the Hydrogel Component of IsoPet®/RadioGel™September 14, 2022 | finance.yahoo.comDua Lipa's LBD Looked Like a Pair of Pants With StrapsAugust 18, 2022 | nz.finance.yahoo.comGreat Elm Group And 3 Other Stocks Under $5 Insiders Are Aggressively BuyingAugust 16, 2022 | uk.investing.comVivos Inc. Announces a New IsoPet® Precision Radionuclide Therapy Regional Clinic for Equine TherapyAugust 16, 2022 | finance.yahoo.comVivos (OTC:RDGL), Analyst Ratings, Price Targets, PredictionsJuly 15, 2022 | benzinga.comVivos (OTC:RDGL), Earnings Estimates, EPS, and RevenueJuly 14, 2022 | benzinga.com Get Vivos News Delivered to You Automatically Sign up to receive the latest news and ratings for RDGL and its competitors with MarketBeat's FREE daily newsletter. Email Address RDGL Media Mentions By Week RDGL Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. RDGL News Sentiment▼0.980.94▲Average Finance News Sentiment RDGL News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. RDGL Articles This Week▼20▲RDGL Articles Average Week Get Vivos News Delivered to You Automatically Sign up to receive the latest news and ratings for RDGL and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies NVRO News Today SKIN News Today CATX News Today BWAY News Today LAKE News Today ELMD News Today CVRX News Today RCEL News Today STXS News Today TLSI News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:RDGL) was last updated on 5/29/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredIs President Trump Lying To You With This?President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to ...Colonial Metals | SponsoredA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredTrump Exec Order 14179 is wealth “gift” to good Americans?Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vivos Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Vivos With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy RDGL Stock Free RDGL Stock Alerts